{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:21:29Z","timestamp":1777378889015,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020537","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jgar.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T01:54:04Z","timestamp":1715046844000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical characteristics and antimicrobial susceptibility profiles of Mycobacterium abscessus and Mycobacterium massiliense pulmonary infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Wanru","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwan","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongkang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangxiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.04.004_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CMR.17.1.98-106.2004","article-title":"Health impacts of environmental mycobacteria","volume":"17","author":"Primm","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2024.04.004_bib0002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0003","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","article-title":"Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov","volume":"66","author":"Tortoli","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fpubh.2020.00295","article-title":"Trends in the prevalence and antibiotic resistance of non-tuberculous mycobacteria in mainland China, 2000-2019: systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.jgar.2024.04.004_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2021.05.019","article-title":"Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: a prospective surveillance study","volume":"83","author":"Tan","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2024.04.004_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijid.2019.01.036","article-title":"Multicenter evaluation of the biochip assay for rapid detection of mycobacterial isolates in smear-positive specimens","volume":"81","author":"Fang","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2024.04.004_bib0008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The rise of non-tuberculosis mycobacterial lung disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2024.04.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0212-2021","article-title":"Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments","volume":"31","author":"Kumar","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jgar.2024.04.004_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkt410","article-title":"Characterization of broad-spectrum Mycobacterium abscessus class A \u03b2-lactamase","volume":"69","author":"Soroka","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0012","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/jac\/dkx284","article-title":"Effect of \u03b2-lactamase production and \u03b2-lactam instability on MIC testing results for Mycobacterium abscessus","volume":"72","author":"Rominski","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02440-16","article-title":"Inhibition of the \u03b2-lactamase Bla(Mab) by avibactam improves the in vitro and in vivo efficacy of imipenem against Mycobacterium abscessus","volume":"61","author":"Lefebvre","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0014","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41598-020-57844-8","article-title":"Effect of amoxicillin in combination with imipenem-relebactam against Mycobacterium abscessus","volume":"10","author":"Lopeman","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2024.04.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00174-18","article-title":"Relebactam is a potent inhibitor of the KPC-2 \u03b2-lactamase and restores imipenem susceptibility in KPC-producing enterobacteriaceae","volume":"62","author":"Papp-Wallace","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0016","article-title":"In vitro activity of the new \u03b2-lactamase inhibitors relebactam and vaborbactam in combination with \u03b2-lactams against Mycobacterium abscessus complex clinical isolates","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0017","first-page":"379","article-title":"Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab \u03b2-lactamase on the in vitro and intracellular efficacy of imipenem","volume":"75","author":"Le Run","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0018","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0019","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2024.04.004_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2024.04.004_bib0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-1135(97)00120-X","article-title":"Identification of mycobacteria infecting fish to the species level using polymerase chain reaction and restriction enzyme analysis","volume":"58","author":"Talaat","year":"1997","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0022","series-title":"CLSI Standards: Guidelines for Health Care Excellence. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011"},{"key":"10.1016\/j.jgar.2024.04.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2024.04.004_bib0024","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10096-019-03771-0","article-title":"Pulmonary non-tuberculous mycobacterial infections: current state and future management","volume":"39","author":"Chin","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","article-title":"Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis","volume":"68","author":"Andr\u00e9jak","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jgar.2024.04.004_bib0026","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1099\/jmm.0.077164-0","article-title":"Mycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes","volume":"63","author":"Harris","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0028","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jmii.2014.08.005","article-title":"Risk factors for microbiologic failure among Taiwanese adults with Mycobacterium abscessus complex pulmonary disease","volume":"48","author":"Tung","year":"2015","journal-title":"Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2024.04.004_bib0029","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijid.2021.12.348","article-title":"Mycobacterium abscessus and Mycobacterium massiliense exhibit distinct host and organ specificity: a cross-sectional study","volume":"116","author":"Hsu","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0031","article-title":"Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271660","article-title":"Radiological findings in nontuberculous mycobacterial pulmonary diseases: a comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex","volume":"17","author":"Nagano","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jgar.2024.04.004_bib0033","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12866-020-01840-5","article-title":"Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jgar.2024.04.004_bib0034","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1097\/MD.0000000000002338","article-title":"Characterization of Mycobacterium abscessus subtypes in Shanghai of China: drug sensitivity and bacterial epidemicity as well as clinical manifestations","volume":"95","author":"Luo","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jgar.2024.04.004_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.rmed.2018.10.012","article-title":"Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan \u2013 an NTM-JRC study with RIT","volume":"145","author":"Morimoto","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jgar.2024.04.004_bib0036","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10096-020-04026-z","article-title":"Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease","volume":"40","author":"Fujiwara","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0037","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.43.12.3001","article-title":"Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex","volume":"43","author":"Tomioka","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0038","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jgar.2021.02.024","article-title":"Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China","volume":"25","author":"Guo","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jgar.2024.04.004_bib0039","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1080\/07853890.2022.2121984","article-title":"Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract","volume":"54","author":"He","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.jgar.2024.04.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01928-21","article-title":"Minimum inhibitory concentrations before and after antibacterial treatment in patients with Mycobacterium abscessus pulmonary disease","volume":"9","author":"Fujiwara","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2024.04.004_bib0041","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.03112-15","article-title":"Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease","volume":"60","author":"Ferro","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0042","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00824-23","article-title":"Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes","volume":"67","author":"El Ghali","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.04.004_bib0044","doi-asserted-by":"crossref","first-page":"ofad335","DOI":"10.1093\/ofid\/ofad335","article-title":"Long-term safety and tolerability of omadacycline for the treatment of Mycobacterium abscessus infections","volume":"10","author":"Mingora","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2024.04.004_bib0045","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2147\/IDR.S252485","article-title":"Antimicrobial susceptibility of Mycobacterium abscessus complex clinical isolates from a Chinese tertiary hospital","volume":"13","author":"Guo","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2024.04.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106669","article-title":"In vitro effects of diazabicyclooctane \u03b2-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex","volume":"60","author":"Misawa","year":"2022","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T09:41:12Z","timestamp":1726393272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"alternative-id":["S2213716524000766"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.04.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and antimicrobial susceptibility profiles of Mycobacterium abscessus and Mycobacterium massiliense pulmonary infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}